Carbon Nanomaterials for Drug Delivery, Tissue Engineering and Cancer Therapy
This community develops graphene, carbon nanotubes, and related nanocomposites to deliver drugs, treat cancer, and support tissue regeneration.
The research focuses heavily on graphene oxide and reduced graphene oxide, which are functionalized to create carriers for targeted drug delivery, particularly for cancer treatments like photothermal therapy. Carbon nanotubes and carbon nanomaterials are also central, used in applications ranging from wound healing and antibacterial activity to bone and peripheral nerve tissue engineering. The work frequently involves synthesizing nanocomposites and assessing their biological interactions, including toxicity and cellular uptake.
The largest share of the community's output is found in carbon research, accounting for 7,145 papers, which represents 0.7% of all tracked carbon research. Oxygen research follows with 682 papers, and silver research with 249 papers.
The community comprises 9,215 papers, with the most frequent venues being Carbon, International Journal of Nanomedicine, and ACS Nano.
Recent work continues to explore the clinical translation of these materials, with specific attention to carbon nanomaterials in anticancer drug delivery, wound healing therapies, and their interactions with immune cells.